US Stock MarketDetailed Quotes

APLT Applied Therapeutics

Watchlist
  • 8.960
  • +0.330+3.82%
Close Oct 18 16:00 ET
  • 8.980
  • +0.020+0.22%
Post 20:01 ET
1.03BMarket Cap-6265P/E (TTM)

Applied Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-37.34%-22.6M
-170.54%-18.91M
29.35%-55.17M
-7.00%-17.01M
24.05%-14.73M
10.59%-16.45M
71.36%-6.99M
13.93%-78.09M
41.01%-15.89M
-23.78%-19.39M
Net income from continuing operations
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
32.79%-19.1M
Operating gains losses
-277.64%-22.75M
13,619.19%63.41M
85,616.67%56.57M
498.64%16.96M
5,818.24%27.28M
193.87%12.8M
-206.35%-469K
--66K
---4.26M
---477K
Depreciation and amortization
5.17%122K
5.26%120K
-20.09%354K
-94.74%6K
6.31%118K
5.45%116K
5.56%114K
6.75%443K
7.55%114K
5.71%111K
Other non cash items
42.08%-512K
-59.94%260K
-44.58%1.74M
-39.55%2.1M
-9.01%-121K
26.52%-884K
-34.25%649K
878.96%3.15M
3,408.57%3.47M
-9.90%-111K
Change In working capital
-130.56%-4.81M
-242.48%-1.14M
83.71%-1.44M
15,381.82%1.7M
52.35%-1.85M
-3,267.74%-2.09M
116.28%798K
-1,340.39%-8.84M
100.29%11K
-143.30%-3.89M
-Change in prepaid assets
-1,301.23%-1.14M
-73.37%-319K
421.45%1.87M
278.74%2.35M
-182.06%-215K
-108.89%-81K
87.18%-184K
121.70%359K
213.53%621K
-30.13%262K
-Change in payables and accrued expense
-570.13%-3.68M
-106.47%-59K
68.58%-2.06M
33.24%-717K
58.87%-1.71M
-125.75%-549K
126.31%912K
-219.85%-6.56M
66.48%-1.07M
-148.22%-4.15M
-Change in other current liabilities
--0
-1,184.29%-759K
-36.42%295K
-85.34%68K
--69K
--88K
--70K
--464K
--464K
--0
-Change in other working capital
----
----
50.21%-1.55M
--0
--0
----
----
29.99%-3.11M
--0
--0
Cash from discontinued investing activities
Operating cash flow
-37.34%-22.6M
-170.54%-18.91M
29.35%-55.17M
-7.00%-17.01M
24.05%-14.73M
10.59%-16.45M
71.36%-6.99M
13.93%-78.09M
41.01%-15.89M
-23.78%-19.39M
Investing cash flow
Cash flow from continuing investing activities
0
0
5.33%13.87M
0
0
0
45.64%13.87M
5.93%13.17M
-158.48%-6.91M
-41.05%5.02M
Net investment purchase and sale
--0
--0
5.33%13.87M
--0
--0
--0
45.64%13.87M
5.93%13.17M
-158.48%-6.91M
-41.05%5.02M
Cash from discontinued investing activities
Investing cash flow
--0
--0
5.33%13.87M
--0
--0
--0
45.64%13.87M
5.93%13.17M
-158.48%-6.91M
-41.05%5.02M
Financing cash flow
Cash flow from continuing financing activities
-105.80%-1.69M
18,668.65%115.5M
169.18%74.54M
3,256.06%29.45M
1,806.18%16.57M
-4.06%29.15M
21.17%-622K
-62.94%27.69M
21.20%-933K
10.09%-971K
Net issuance payments of debt
--0
50.00%-311K
43.23%-1.86M
50.16%-465K
50.11%-465K
50.57%-306K
21.17%-622K
30.63%-3.27M
21.20%-933K
21.28%-932K
Net common stock issuance
-107.18%-2M
--106.75M
131.97%64.51M
--29.91M
7,731.82%6.72M
--27.89M
--0
-62.63%27.81M
--0
---88K
Proceeds from stock option exercised by employees
1,376.19%310K
--9.06M
21,002.04%10.34M
--3K
20,953.06%10.32M
--21K
--0
-91.55%49K
--0
-52.88%49K
Net other financing activities
----
----
-50.21%1.55M
--0
--0
----
----
-29.97%3.11M
--0
--0
Cash from discontinued financing activities
Financing cash flow
-105.80%-1.69M
18,668.65%115.5M
169.18%74.54M
3,256.06%29.45M
1,806.18%16.57M
-4.06%29.15M
21.17%-622K
-62.94%27.69M
21.20%-933K
10.09%-971K
Net cash flow
Beginning cash position
539.19%146.48M
199.56%49.9M
-69.09%16.66M
-7.26%37.46M
-36.09%35.62M
-40.03%22.92M
-69.09%16.66M
-6.23%53.89M
-42.47%40.39M
-28.95%55.73M
Current changes in cash
-291.25%-24.29M
1,442.91%96.59M
189.28%33.24M
152.43%12.44M
112.00%1.84M
-27.49%12.7M
139.94%6.26M
-940.55%-37.23M
-45.42%-23.73M
-86.46%-15.34M
End cash Position
243.10%122.2M
539.19%146.48M
199.56%49.9M
199.56%49.9M
-7.26%37.46M
-36.09%35.62M
-40.03%22.92M
-69.09%16.66M
-69.09%16.66M
-42.47%40.39M
Free cash flow
-37.34%-22.6M
-170.54%-18.91M
29.35%-55.17M
-7.00%-17.01M
24.05%-14.73M
10.59%-16.45M
71.36%-6.99M
13.93%-78.09M
41.01%-15.89M
-23.78%-19.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -37.34%-22.6M-170.54%-18.91M29.35%-55.17M-7.00%-17.01M24.05%-14.73M10.59%-16.45M71.36%-6.99M13.93%-78.09M41.01%-15.89M-23.78%-19.39M
Net income from continuing operations 109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M32.79%-19.1M
Operating gains losses -277.64%-22.75M13,619.19%63.41M85,616.67%56.57M498.64%16.96M5,818.24%27.28M193.87%12.8M-206.35%-469K--66K---4.26M---477K
Depreciation and amortization 5.17%122K5.26%120K-20.09%354K-94.74%6K6.31%118K5.45%116K5.56%114K6.75%443K7.55%114K5.71%111K
Other non cash items 42.08%-512K-59.94%260K-44.58%1.74M-39.55%2.1M-9.01%-121K26.52%-884K-34.25%649K878.96%3.15M3,408.57%3.47M-9.90%-111K
Change In working capital -130.56%-4.81M-242.48%-1.14M83.71%-1.44M15,381.82%1.7M52.35%-1.85M-3,267.74%-2.09M116.28%798K-1,340.39%-8.84M100.29%11K-143.30%-3.89M
-Change in prepaid assets -1,301.23%-1.14M-73.37%-319K421.45%1.87M278.74%2.35M-182.06%-215K-108.89%-81K87.18%-184K121.70%359K213.53%621K-30.13%262K
-Change in payables and accrued expense -570.13%-3.68M-106.47%-59K68.58%-2.06M33.24%-717K58.87%-1.71M-125.75%-549K126.31%912K-219.85%-6.56M66.48%-1.07M-148.22%-4.15M
-Change in other current liabilities --0-1,184.29%-759K-36.42%295K-85.34%68K--69K--88K--70K--464K--464K--0
-Change in other working capital --------50.21%-1.55M--0--0--------29.99%-3.11M--0--0
Cash from discontinued investing activities
Operating cash flow -37.34%-22.6M-170.54%-18.91M29.35%-55.17M-7.00%-17.01M24.05%-14.73M10.59%-16.45M71.36%-6.99M13.93%-78.09M41.01%-15.89M-23.78%-19.39M
Investing cash flow
Cash flow from continuing investing activities 005.33%13.87M00045.64%13.87M5.93%13.17M-158.48%-6.91M-41.05%5.02M
Net investment purchase and sale --0--05.33%13.87M--0--0--045.64%13.87M5.93%13.17M-158.48%-6.91M-41.05%5.02M
Cash from discontinued investing activities
Investing cash flow --0--05.33%13.87M--0--0--045.64%13.87M5.93%13.17M-158.48%-6.91M-41.05%5.02M
Financing cash flow
Cash flow from continuing financing activities -105.80%-1.69M18,668.65%115.5M169.18%74.54M3,256.06%29.45M1,806.18%16.57M-4.06%29.15M21.17%-622K-62.94%27.69M21.20%-933K10.09%-971K
Net issuance payments of debt --050.00%-311K43.23%-1.86M50.16%-465K50.11%-465K50.57%-306K21.17%-622K30.63%-3.27M21.20%-933K21.28%-932K
Net common stock issuance -107.18%-2M--106.75M131.97%64.51M--29.91M7,731.82%6.72M--27.89M--0-62.63%27.81M--0---88K
Proceeds from stock option exercised by employees 1,376.19%310K--9.06M21,002.04%10.34M--3K20,953.06%10.32M--21K--0-91.55%49K--0-52.88%49K
Net other financing activities ---------50.21%1.55M--0--0---------29.97%3.11M--0--0
Cash from discontinued financing activities
Financing cash flow -105.80%-1.69M18,668.65%115.5M169.18%74.54M3,256.06%29.45M1,806.18%16.57M-4.06%29.15M21.17%-622K-62.94%27.69M21.20%-933K10.09%-971K
Net cash flow
Beginning cash position 539.19%146.48M199.56%49.9M-69.09%16.66M-7.26%37.46M-36.09%35.62M-40.03%22.92M-69.09%16.66M-6.23%53.89M-42.47%40.39M-28.95%55.73M
Current changes in cash -291.25%-24.29M1,442.91%96.59M189.28%33.24M152.43%12.44M112.00%1.84M-27.49%12.7M139.94%6.26M-940.55%-37.23M-45.42%-23.73M-86.46%-15.34M
End cash Position 243.10%122.2M539.19%146.48M199.56%49.9M199.56%49.9M-7.26%37.46M-36.09%35.62M-40.03%22.92M-69.09%16.66M-69.09%16.66M-42.47%40.39M
Free cash flow -37.34%-22.6M-170.54%-18.91M29.35%-55.17M-7.00%-17.01M24.05%-14.73M10.59%-16.45M71.36%-6.99M13.93%-78.09M41.01%-15.89M-23.78%-19.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data